Pfizer (NYSE: PFE) CEO receives phantom stock unit award under deferred plan

Rhea-AI Filing Summary

BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

PFIZER INC Chairman & CEO Albert Bourla received a compensation-related grant of 22 Phantom Stock Units on common stock. The units were valued at $27.19 each and are part of Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan.

The phantom units are settled in cash after his separation from service and can be moved into an alternative investment account at any time. Following this grant, Bourla holds a total of 760,070 Phantom Stock Units directly under this plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP	22	$27.19	$598.18

Holdings After Transaction: Phantom Stock Units SSP — 760,070 shares (Direct)

Footnotes (1)

1. Each unit represents one phantom share of common stock. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom Stock Units granted: 22 units Grant value per unit: $27.19 per unit Total Phantom Stock Units after grant: 760,070 units +2 more

5 metrics

Phantom Stock Units granted 22 units Compensation grant on April 15, 2026

Grant value per unit $27.19 per unit Value assigned to each Phantom Stock Unit

Total Phantom Stock Units after grant 760,070 units Balance following reported transaction

Underlying security shares 22 shares equivalent Each unit represents one phantom share of common stock

Conversion or exercise price $0.00 Phantom units under deferred compensation plan

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Supplemental Savings Plan, phantom share

3 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash"

phantom share financial

"Each unit represents one phantom share of common stock."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units SSP	(1)	04/15/2026		A		22		(2)	(2)	Common Stock	22	$27.19	760,070	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Pfizer (PFE) CEO Albert Bourla report in this Form 4 filing?

Albert Bourla reported receiving 22 Phantom Stock Units as a compensation grant. These units are tied to Pfizer common stock, valued at $27.19 each, and are part of the company’s nonfunded deferred compensation and supplemental savings plan.

Are Albert Bourla’s Phantom Stock Units in Pfizer (PFE) settled in shares or cash?

The Phantom Stock Units are settled in cash after Bourla’s separation from service. Each unit tracks one phantom share of Pfizer common stock, but the plan explicitly provides for cash settlement rather than delivery of actual Pfizer shares.

How many Phantom Stock Units in Pfizer (PFE) does Albert Bourla hold after this grant?

After the reported grant, Albert Bourla holds 760,070 Phantom Stock Units. This total reflects his accumulated phantom units under Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan, including the newly awarded 22 units.

What is the value per Phantom Stock Unit granted to Pfizer (PFE) CEO Albert Bourla?

Each Phantom Stock Unit in this grant is valued at $27.19 per unit. The award therefore represents a small incremental addition to Bourla’s existing phantom unit balance within Pfizer’s deferred compensation framework.

Can Albert Bourla reallocate his Pfizer (PFE) Phantom Stock Units before separation?

Yes. Under the plan, Bourla may transfer the Phantom Stock Units into an alternative investment account at any time. However, ultimate settlement occurs in cash after his separation from service, consistent with the plan’s deferred compensation design.